"Most of the vaccinated were between 20 and 59 years old and the largest number of doses were administered in France," explained the researchers, who specified that the vaccines came from the Pfizer, Moderna and AstraZeneca laboratories. The results obtained have not reassured health professionals, let alone patients.
Guillain-Barré syndrome and venous thrombosis (9/10)
Researchers have noticed an increase in the number of Guillain-Barré syndromes as well as cerebral venous thrombosis after the injection of the first dose of the AstraZeneca vaccine. Guillain-Barré syndrome is mainly characterized by muscle weakness, while venous thrombosis is the formation of a blood clot in a vein, preventing the proper circulation of blood in the body. The French NBA star, Victor Wembanyama, was affected by this last case a few months ago, having to end his season.
More research needed (10/10)
read more in next page
